Management Forum Logo

Presented by
Management Forum

CAPA (Corrective and Preventative Action) Training Course

This course will cover CAPA methodology and documentation, diagnosing process improvement, developing options for process improvement, and planning and implementation in process improvements and CAPA.

19 July 2024
+ 13 December 2024 »

from £549

Need help?  Enrol or reserve

Course Overview

In today’s highly regulated pharma, biotech, device and animal health industries, it is essential to use the most efficient processes and ensure compliance with an active corrective and preventive action (CAPA) system.

CAPA procedures are a frequent focus of regulatory inspectors and evidence will be required at any future inspections that CAPA actions have been implemented.

This course will provide you with an understanding of how to improve your processes and implement and document an effective CAPA quality system. The programme will include discussion of CAPA examples and case studies to enhance course learning.

Benefits of attending:
  • Understand CAPA methodology and documentation
  • Learn tools and techniques to help make your existing processes more efficient and compliant
  • Discover how you can address inspection findings using CAPA and process improvement
  • Share best practice for CAPA

This course is part of our Regulatory Affairs Training course collection, which features updates on the latest regulations to registration procedures and strategies.

Who Should Attend?

This course has been specifically designed for those working in the pharma, biotech, device or animal health industries who are involved in process improvement and CAPA requirements.

Enrol or reserve

The CAPA (Corrective and Preventative Action) course will cover:

Why is CAPA Important?

Best Practice for CAPA

CAPA Methodology and Documentation

  • Identification
  • Evaluation
  • Investigation
  • Analysis
  • Action plan
  • Implementation – execute the action plan, eg stakeholder analysis, the transition curve
  • Follow-up – verify and assess the effectiveness of the CAPA
  • Finding(s)

Diagnosing Process Improvement

  • Using problem diagnosis (eg ‘root cause’ analysis) to understand why processes are unwieldy and help facilitate how to resolve inspection and audit findings

Developing Options for Process Improvement and CAPA

  • Being more creative in problem solving of process simplification issues
  • Flowcharts
  • Evaluation of the attractiveness/likely difficulty of changes
  • Continuous improvement – an invaluable approach for improving the implementation of regulatory change

Planning and Implementation in Process Improvements and CAPA

  • Project managing process improvements and CAPA
  • Managing the change and people issues
  • Managing the stakeholders involved (stakeholder analysis)

Enrol or reserve

Laura Brown
LB Training and Development Ltd

Dr Laura Brown is an independent pharmaceutical QA consultant and is a recognised expert in QA including auditing SOPs for regulatory compliance. She has more than 25 years’ international experience in the pharmaceutical industry in a number of senior roles and has worked for companies including GSK, Hoechst Marion Roussel, Farmitalia and Phoenix International. She has worked in several quality assurance roles which have included writing, reviewing and auditing SOPs and CAPA implementation and has helped companies prepare SOPs and review CAPA systems to meet regulatory requirements.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

19 July 2024

Live online

09:30-17:00 UK (London) (UTC+01)
10:30-18:00 Paris (UTC+02)
04:30-12:00 New York (UTC-04)
Course code 13815

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 14 Jun

View basket 

 
Not ready to book yet?

for 7 days, no obligation

13 December 2024

Live online

09:30-17:00 UK (London) (UTC+00)
10:30-18:00 Paris (UTC+01)
04:30-12:00 New York (UTC-05)
Course code 14089

  • GBP 549 649
  • EUR 789 929
  • USD 893 1,049

Until 08 Nov

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

United Kingdom

  • Torbay Pharmaceuticals
  • A.Menarini Farmaceutica Int SRL
  • Abbott Healthcare Products Ltd
  • Abbott Laboratories Ltd
  • ADAMAS Consulting Ltd
  • Allergan Limited
  • Alliance Healthcare
  • Animalcare
  • Animax Ltd
  • Arnold & Porter (UK) LLP
  • Associates of Cape Cod Inc
  • AstraZeneca
  • AstraZeneca R&D Charnwood
  • AstraZeneca UK Ltd
  • Bayer Healthcare
  • Bayer plc
  • Besins Healthcare Pharma Services
  • Bespak Europe Ltd
  • Biogen
  • BOC Micro applications centre
  • Bray Group Ltd
  • Carclo Technical Plastics
  • Celgene Europe Ltd
  • Chesapeake Pharmaceutical & Healthcare Packaging
  • Chiesi
  • Colorcon
  • Colorcon Limited
  • DA Consulting Ltd
  • Daiichi Sankyo UK Ltd
  • Depuy CMW
  • DHL Hospital Logistics Centre
  • DHLSupply Chain
  • Eisai Europe Limited
  • Flexible Medical Packaging Ltd
  • FMP Ltd
  • Food Standards Agency
  • Goldenzone Ltd
  • GSK
  • GW Pharmaceuticals
  • GW Pharmaceuticals Limited
  • GW Pharmaceuticals plc
  • Imanova Limited
  • Interport Ltd
  • Ipsen
  • JensonR+
  • KPMG
  • Kyowa Kirin International plc
  • Magstim Company Ltd
  • Mediplus
  • Mercury Pharma Management Services Ltd
  • Mexichem
  • Morningside Healthcare Limited
  • MSD Ltd
  • Mundipharma Research Ltd
  • Necessity Supplies Ltd
  • Novo Nordisk Ltd
  • Nutricia Ltd
  • Owen Mumford Ltd
  • Oxford Pharmascience
  • Panacea Pharma Projects
  • Pfizer Limited
  • Pharmaspec Specials
  • Philips Respironics
  • Procter & Gamble
  • ProductLife Limited
  • ProductLife Ltd
  • Public Health England
  • Rayner Intraocular Lenses Ltd
  • Reckitt Benckiser Group
  • Regulis Consulting Limited
  • Regulis Consulting Ltd
  • Remote Diagnostic Technologies Ltd
  • Roche Products Ltd
  • Sanofi Pasteur MSD Ltd
  • Sekisui Diagnostics (UK) Ltd
  • Sharp Life Science (EU) Ltd
  • SincasPharma
  • Takeda Development Centre Europe Ltd
  • Teva UK Ltd
  • The Magstim Company Ltd
  • The National Artificial Eye Service
  • The Straumann Group
  • Torbay Pharmaceuticals
  • University Hospitals Plymouth NHS Trust
  • University of Cambridge
  • Vifor Pharma UK Limited
  • Wesley Coe (Cambridge) Limited

Switzerland

  • Actelion A Janssen Pharmaceutical Company of Johns
  • Actelion Pharmaceutical Ltd
  • Bayer Consumer Care AG
  • Bernafon
  • Celgene International
  • Celgene International Sarl
  • F. Hoffmann-La Roche Ltd
  • GSK Consumer Healthcare S.A
  • IBSA SA
  • Idorsia Pharmaceuticals Ltd
  • Merck Serono SA
  • Novartis Consumer Health SA
  • Skan AG

Belgium

  • Chiesi SA NV
  • EORTC
  • Genzyme Flanders NV/SA
  • IBA
  • International Bar News
  • Ion Beam Applications SA
  • Keyrus Biopharma
  • s.a. Lundbeck nv
  • SGS Belgium NV Life Science Services
  • UCB Pharma SA
  • Words & Science

Denmark

  • Actavis A/S
  • Boehringer-Ingelheim Danmark A/S
  • Copenhagen HIV Programme
  • Ferring Pharmaceuticals A/S
  • H. Lundbeck A/S
  • LEO Pharma A/S
  • Neurodan A/S
  • Novo Nordisk A/S. Company Member no. 3431
  • Pharmacosmos A/S
  • SSI Diagnostica
  • Takeda Pharma A/S

Germany

  • AWD Pharma GmbH & Co KG
  • Bayer Pharma AG
  • Berlin-Chemie AG
  • Medac GmbH
  • Merck KGaA
  • MorphoSys AG
  • MSD AH Innovation GmbH
  • Mundipharma Research GmbH & Co Kg

Netherlands

  • Astellas BV
  • Aurobindo Pharma B.V.
  • Bayer Medical Care BV
  • Boehringer Ingelheim BV
  • Genzyme Europe BV
  • Intervet International BV MSD Animal Health
  • Janssen Biologics BV
  • Zoetis

Italy

  • Menarini Ricerche S.p.A.
  • Actelion Pharmaceuticals Italia Srl
  • Alfa Wassermann S.p.A.
  • Alfrapharma Srl
  • Chiesi Farmaceutici SPA
  • Novartis Vaccines & Diagnostics SRL
  • Zambon S.p.A.

France

  • ALEXION Europe SAS
  • Institut de Rercherches Internationales Servier
  • Pierre Fabre Medicament
  • Sanofi Pasteur Siege mondial
  • Sanofi-Aventis R&D

Slovak Republic

  • Ewopharma International s.r.o
  • EWOPHARMA International s.r.o.
  • Ewopharma International, s.r.o.

Spain

  • Almus Farmaceutica
  • Industrias Farmaceuticas Almiral S.A.
  • Laboratorios CINFA

Hungary

  • EGIS Pharmaceuticals PLC
  • Mylan Hungary Kft

Israel

  • Roche (Israel) Pharmaceuticals
  • TEVA

Malta

  • Orphalan Ltd
  • Orphalan Ltd.

Norway

  • Institute for Energy Technology
  • VESO Vikan

Romania

  • Ewopharma AG
  • SC Pharma Serv International Srl

Slovenia

  • Medis d.o.o
  • Salus, Veletrgovina, d.o.o

Turkey

  • Boehringer Ingelheim
  • Boehringer Ingelheim Ilaç Tic. A.S.

Croatia

  • PrimeVigilance Zagreb d.o.o.

Czech Republic

  • Arriello

India

  • Cipla Ltd

Latvia

  • JSC Olainfarm

Sweden

  • CTC Clinical Trial Consultants AB

Ukraine

  • SmartlineGroup

United States of America

  • Celgene

Enrol or reserve

Run CAPA (Corrective and Preventative Action) Live online for your team

1 day

Typical duration

Pricing from:

  • GBP 450
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra BEER
Training expert

Yesim Nurko

Yesim NURKO
Training expert

+44 (0)20 7749 4749

inhouse@ipi.academy